What are Polyphenolic antioxidant drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Polyphenolic antioxidant drugs are pharmacologic agents that share a common mechanism (typically targeting SIRT1, NF-κB pathway). 0 are currently marketed, with 2 more in clinical development.

Polyphenolic antioxidant

0 marketed 2 in Phase 3

This page covers all Polyphenolic antioxidant drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting SIRT1, NF-κB pathway, SIRT1, general antioxidant pathways, AMPK.

Targets

SIRT1, NF-κB pathway · SIRT1, general antioxidant pathways, AMPK

Phase 3 pipeline (2)

Resveratrol nasal spray · University of Campania Luigi Vanvitelli · Neurology, Inflammation, Respiratory
Resveratrol is a polyphenolic antioxidant that activates sirtuins and other cellular pathways to reduce inflammation and oxidative stress.
Mega Resveratrol® capsules · Sun Yat-sen University · Cardiovascular, Neurology, Anti-aging, General wellness
Resveratrol acts as a polyphenolic antioxidant and sirtuin activator that reduces oxidative stress and modulates cellular signaling pathways involved in aging and disease.

Patent intelligence

polyphenolic antioxidant patent landscape — aggregated cliff calendar, attackable patents, originator estates